[100% Off] Regulatory Affair-Drug Development (Inda) Certificate Course
Investigational New Drug, IND Review, Basic for INDA, USFDA regulations, FDA Meetings, Non-clinical study, Updating INDA
Requirements
- Life-Science background
- Pharmaceutical background
- Master of pharmacy
- Bachelors of pharmacy
- Pharma industrial Regulatory Affairs
- Regulatory affairs professional
Description
Developing New Drugs
Unlock new job opportunities and advance your career in the pharmaceutical industry by gaining critical skills in regulatory affairs, drug development, and U.S. FDA processes.
This course provides in-depth knowledge of the Investigational New Drug (IND) application, U.S. FDA regulatory guidelines, non-clinical studies, and the complete process of bringing a drug to market. Whether you’re a student, researcher, or working professional, this is your chance to upgrade your profile with job-ready skills in the high-demand regulatory field.
This course will give you insights on Investigational New Drug, IND Review, Basic for INDA, USFDA regulations, Nonclinical study overview, Updating INDA
Before a drug can be tested in people, the drug company or sponsor performs laboratory and animal tests to discover how the drug works and whether it’s likely to be safe and work well in humans. Next, a series of tests in people is begun to determine whether the drug is safe when used to treat a disease and whether it provides a real health benefit.
Drug development and approval process:
The mission of FDA’s Center for Drug Evaluation and Research (CDER) is to ensure that drugs marketed in this country are safe and effective. CDER does not test drugs, although the Center’s Office of Testing and Research does conduct limited research in the areas of drug quality, safety, and effectiveness.
Some companies submit a new drug application (NDA) to introduce a new drug product into the U.S. Market. It is the responsibility of the company seeking to market a drug to test it and submit evidence that it is safe and effective. A team of CDER physicians, statisticians, chemists, pharmacologists, and other scientists reviews the sponsor’s NDA containing the data and proposed labeling.
What You’ll Learn
The Drug Development Process from lab to market
Investigational New Drug (IND) application & review procedures
Basics of INDA (Investigational New Drug Application)
Overview of non-clinical (preclinical) studies
Key USFDA regulations you must know
How CDER (Center for Drug Evaluation and Research) evaluates drug safety and efficacy
Course Benefits
Gain job-oriented skills in regulatory affairs
Improve chances of selection in pharma interviews
Add a valuable skill to your professional resume
Stay updated with the latest developments in drug regulations
Learn directly applicable knowledge for roles in FDA submissions and approvals
Course Format
100% online and self-paced
No prerequisites required – just curiosity and a background in science or healthcare
Certificate of Completion provided
Lifetime access to course content
By the End of This Course, You Will:
Understand how new drugs are developed and approved
Be familiar with the regulatory frameworks of the U.S. FDA
Be ready to apply for roles in research and regulatory departments
Enhance your profile with in-demand pharmaceutical skills
Prerequisites: No prerequisites required, only need curiosity towards learning and science background.
Achivements after course:
Certificate of completion.
Add on skill.
You can update your professional profile.
New job opportunities in research.
Life time access to course.
Upgrade your skills and knowledge in clinical research.
Author(s): Mahesh Pratapwar
